We are live on ! Find out more
BI

Boulegeris Investments Portfolio holdings

AUM $200M
1-Year Est. Return 7%
This Fund
S&P 500
This Quarter Est. Return
+4.21%
1 Year Est. Return
+7%
3 Year Est. Return
+39.11%
5 Year Est. Return
10 Year Est. Return
AUM
$177M
AUM Growth
+$9.96M
Cap. Flow
+$3.69M
Cap. Flow %
2.09%
Top 10 Hldgs %
73.73%
Holding
54
New
2
Increased
33
Reduced
10
Closed
2

Top Sells

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$1.4M
2
WBA
Walgreens Boots Alliance
WBA
+$1.11M
3
DIS icon
Walt Disney
DIS
+$376K
4
AAPL icon
Apple
AAPL
+$374K
5
NNN icon
NNN REIT
NNN
+$220K

Sector Composition

Rank Sector Weight
1 Real Estate 42.01%
2 Healthcare 16.47%
3 Consumer Staples 8.62%
4 Technology 5.88%
5 Consumer Discretionary 5.32%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KTOS icon
51
Kratos Defense & Security Solutions
KTOS
$8.23B
$175K 0.1%
14,725
+650
+5% +$6.21K
NGD
52
DELISTED
New Gold Inc
NGD
$64K 0.04%
+20,000
New +$60K
GILD icon
53
Gilead Sciences
GILD
$165B
-20,582
Closed -$1.4M
WBA
54
DELISTED
Walgreens Boots Alliance
WBA
-13,355
Closed -$1.11M

Similar funds

Boulegeris Investments's Q2 2017 Portfolio in Review

As of Q2 2017, Boulegeris Investments held 54 positions worth $177M, up 6% from $167M the previous quarter. Its ten largest holdings account for 74% of the portfolio.

Boulegeris Investments's Q2 2017 filing shows 2 new, 33 increased, 10 reduced and 2 closed positions. Its largest new stake was CBL& Associates Properties, Inc.: 77,025 shares worth $649K. The largest sale was Gilead Sciences, an estimated $1.4M.

By sector, the portfolio is most concentrated in Real Estate at 42% of assets, up from 41% a quarter earlier, followed by Healthcare and Consumer Staples.

  • Boulegeris Investments's largest Q2 2017 buy was CBL& Associates Properties, Inc.: 77,025 shares worth $649K.
  • Boulegeris Investments added most to Johnson & Johnson in Q2 2017, an estimated $924K increase.
  • Boulegeris Investments's biggest Q2 2017 reduction was Walt Disney, cutting an estimated $376K.
  • Boulegeris Investments fully exited Gilead Sciences in Q2 2017, selling an estimated $1.4M.
  • Boulegeris Investments's ten largest holdings make up 74% of its $177M portfolio in Q2 2017.
  • Boulegeris Investments opened 2 new positions and closed 2 in Q2 2017.
  • Boulegeris Investments's portfolio value rose 6% quarter-over-quarter to $177M.

Based on Boulegeris Investments's 13F filing for Q2 2017, filed 8 Aug 2017.